Prevalence and characterization of extended-spectrum β-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals

Alobwede, 2003, CTX-M extended-spectrum beta-lactamase arrives in the UK, J Antimicrob Chemother, 51, 470, 10.1093/jac/dkg096

Bauernfeind, 1996, Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase, Antimicrob Agents Chemother, 40, 616, 10.1128/AAC.40.3.616

Bell, 2002, Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa, Diagn Microbiol Infect Dis, 42, 193, 10.1016/S0732-8893(01)00353-4

Bou, 2002, Identification and broad dissemination of the CTX-M-14 beta-lactamase in different Escherichia coli strains in the northwest area of Spain, J Clin Microbiol, 40, 4030, 10.1128/JCM.40.11.4030-4036.2002

Bradford, 2001, Extended-spectrum beta-lactamases in the 21st century, Clin Microbiol Rev, 14, 933, 10.1128/CMR.14.4.933-951.2001

Brinboim, 1979, A rapid alkaline extraction procedure for screening recombinant plasmid DNA, Nucleic Acid Res, 7, 1513, 10.1093/nar/7.6.1513

Chanawong, 2002, Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China, Antimicrob Agents Chemother, 46, 630, 10.1128/AAC.46.3.630-637.2002

Coque, 2002, Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000), Antimicrob Agents Chemother, 46, 500, 10.1128/AAC.46.2.500-510.2002

Coudron, 2000, Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center, J Clin Microbiol, 38, 1791, 10.1128/JCM.38.5.1791-1796.2000

Dutour, 2002, CTX-M-1, CTX-M-3, and CTX-M-14 beta-lactamases from Enterobacteriaceae isolated in France, Antimicrob Agents Chemother, 46, 534, 10.1128/AAC.46.2.534-537.2002

Ena, 1998, Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones, Diagn Microbiol Infect Dis, 30, 103, 10.1016/S0732-8893(97)00216-2

Essack, 2001, Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa, Antimicrob Agents Chemother, 45, 88, 10.1128/AAC.45.1.88-95.2001

French, 1996, Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam/beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase, J Clin Microbiol, 34, 358, 10.1128/jcm.34.2.358-363.1996

Itokazu, 1996, Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units, Clin Infect Dis, 23, 779, 10.1093/clinids/23.4.779

Jones, 1997, Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group, Diagn Microbiol Infect Dis, 29, 265, 10.1016/S0732-8893(97)00157-0

Karim, 2001, Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1, FEMS Microbiol Lett, 201, 237

Kariuki, 2001, Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya, Antimicrob Agents Chemother, 45, 2141, 10.1128/AAC.45.7.2141-2143.2001

Lautenbach, 2001, Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae, Clin Infect Dis, 33, 1288, 10.1086/322667

Lemozy, 1995, First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains, Antimicrob Agents Chemother, 39, 2580, 10.1128/AAC.39.11.2580

Livermore, 1995, Beta-lactamases in laboratory and clinical resistance, Clin Microbiol Rev, 8, 557, 10.1128/CMR.8.4.557

Livermore, 1996, Antibiotic resistance and production of ESBLs amongst Klebsiella spp from intensive care units in Europe, J Antimicrob Chemother, 38, 409, 10.1093/jac/38.3.409

Matthew, 1975, The use of analytical isoelectric focusing for detection and identification of beta-lactamases, J Gen Microbiol, 88, 169, 10.1099/00221287-88-1-169

Matushek, 1996, Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis, J Clin Microbiol, 34, 2598, 10.1128/jcm.34.10.2598-2600.1996

Mavroidi, 2002, CTX-M-3 beta-lactamase-producing Escherichia coli from Greece, Microb Drug Resist, 8, 35, 10.1089/10766290252913737

National Committee for Clinical Laboratory Standards (NCCLS) (2001). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS approved standard M7-A5. Wayne, PA, USA

Neuhauser, 2003, Antibiotic resistance among gram-negative bacilli in US intensive care units, JAMA, 289, 885, 10.1001/jama.289.7.885

Odeh, 2002, Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli, Clin Infect Dis, 35, 140, 10.1086/340742

Pagani, 2003, Multiple CTX-M-type extended-spectrum beta-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy, J Clin Microbiol, 41, 4264, 10.1128/JCM.41.9.4264-4269.2003

Pai, 2001, Identification of CTX-M-14 extended-spectrum beta-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea, J Clin Microbiol, 39, 3747, 10.1128/JCM.39.10.3747-3749.2001

Pfaller, 1999, Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia, Diagn Microbiol Infect Dis, 35, 235, 10.1016/S0732-8893(99)00077-2

Quinteros, 2003, Extended-spectrum beta-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals, Antimicrob Agents Chemother, 47, 2864, 10.1128/AAC.47.9.2864-2867.2003

Rice, 2000, High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae, Antimicrob Agents Chemother, 44, 362, 10.1128/AAC.44.2.362-367.2000

Smith Moland, 2003, Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five U.S. states, Antimicrob Agents Chemother, 47, 2382, 10.1128/AAC.47.7.2382-2383.2003

Spanu, 2002, Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy, Antimicrob Agents Chemother, 46, 196, 10.1128/AAC.46.1.196-202.2002

Tzouvelakis, 2000, CTX-M-type beta-lactamases, Int J Antimicrob Agents, 14, 137

Villegas, 2004, CTX-M-12 β-Lactamase in a Klebsiella pneumoniae clinical isolate in Colombia, Antimicrob Agents Chemother, 48, 629, 10.1128/AAC.48.2.629-631.2004

Wang, 2003, Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases, Antimicrob Agents Chemother, 47, 790, 10.1128/AAC.47.2.790-793.2003

Weinstein, 2001, Controlling antimicrobial resistance in hospitals, Emerging Infect Dis, 7, 188, 10.3201/eid0702.010206

Wiener, 1999, Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes, JAMA, 281, 517, 10.1001/jama.281.6.517

Winokur PL, Canton R, Casellas JM, Legakis N (2001). Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific region. Clin Infect Dis 32:S94–S103